TrialX
Image

Understanding Risk Perception Behaviour and Attitudes Related to Other New Tobacco Products Among Youth

Understanding Risk Perception Behaviour and Attitudes Related to Other New Tobacco Products Among Youth

Recruiting
12-25 years
All
Phase N/A

Overview

To understand the risk perception, behaviour, and attitudes related to electronic cigarettes and other tobacco products among youth.

Description

Phase I Individual qualitative interviews will be conducted to understanding the needs and concerns of youth smokers of e-cigarette or other new tobacco products, including their risk perceptions, and the behaviour, attitudes, and experiences related to these products.

Phase II The findings from the interview in phase I will guide the development of a structure questionnaire for a cross-sectional survey to further explore the behaviour, attitudes, and experiences related to e-cigarette or other new tobacco products among youth.

The findings of this study have important implications for research and clinical practice. Understanding how youth smokers perceive the risks of using e-cigarette and other new tobacco products, and their behaviour, attitudes, experiences related to smoking to help them achieve smoking abstinence. Moreover, the results of this study can understand the misconceptions about e-cigarette and other new tobacco product among youth, increase their perception of the risks of continued smoking and benefits of quitting.

Eligibility

Inclusion Criteria:

  • Youth smokers who contacted the Youth Quitline will be eligible to be included in this study if they (1) are ethnic Chinese; (2) are aged 25 years; (3) are ever user of e-cigarette or any new tobacco products; and (4) spoke Cantonese.

Exclusion Criteria:

  • psychologically or physically unable to communicate

Study details
    Smoking Cessation
    Smoking Cessation

NCT04416698

The University of Hong Kong

5 August 2020

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.